Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones

Jul 17

DJ Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rose 1.88% to $486.03 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.51% to 7,533.77 and Dow Jones Industrial Average falling 0.20% to 52,552.97.

This was the stock's second consecutive day of gains.

Vertex Pharmaceuticals Inc. closed 8.93% below its 52-week high of $533.67, which the company reached on July 7th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ rose 4.21% to $254.39, Krystal Biotech Inc. (KRYS) fell 2.41% to $341.79, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 3.29% to $6.18.

Trading volume (1.4 M) remained 237,521 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 16, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

July 16, 2026 16:36 ET (20:36 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2652422122"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2652422122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2652422122?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-17 04:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2652422122","market":"sh","top_or_hot":-1,"title":"Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Vertex Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VRTX\">$(VRTX)$</a> rose 1.88% to $486.03 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index  falling 0.51% to 7,533.77 and Dow Jones Industrial Average  falling 0.20% to 52,552.97. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Vertex Pharmaceuticals Inc. closed 8.93% below its 52-week high of $533.67, which the company reached on July 7th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. <a href=\"https://laohu8.com/S/ABBV\">$(ABBV)$</a> rose 4.21% to $254.39, <a href=\"https://laohu8.com/S/KRYS\">Krystal Biotech Inc.</a> (KRYS) fell 2.41% to $341.79, and Arcturus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Holdings Inc. <a href=\"https://laohu8.com/S/ARCT\">$(ARCT)$</a> fell 3.29% to $6.18. \n</p>\n<p>\n     Trading volume (1.4 M) remained 237,521 below its 50-day average volume of 1.6 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 16, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 16, 2026 16:36 ET (20:36 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-17 04:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Vertex Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VRTX\">$(VRTX)$</a> rose 1.88% to $486.03 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index  falling 0.51% to 7,533.77 and Dow Jones Industrial Average  falling 0.20% to 52,552.97. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Vertex Pharmaceuticals Inc. closed 8.93% below its 52-week high of $533.67, which the company reached on July 7th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. <a href=\"https://laohu8.com/S/ABBV\">$(ABBV)$</a> rose 4.21% to $254.39, <a href=\"https://laohu8.com/S/KRYS\">Krystal Biotech Inc.</a> (KRYS) fell 2.41% to $341.79, and Arcturus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Holdings Inc. <a href=\"https://laohu8.com/S/ARCT\">$(ARCT)$</a> fell 3.29% to $6.18. \n</p>\n<p>\n     Trading volume (1.4 M) remained 237,521 below its 50-day average volume of 1.6 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 16, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 16, 2026 16:36 ET (20:36 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VERX","symbol_name":"Vertex, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2652422122","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2652422122","pubTimestamp":1784234160,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Vertex Pharmaceuticals Inc.  rose 1.88% to $486.03 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.51% to 7,533.77 and Dow Jones Industrial Average  falling 0.20% to 52,552.97.This was the stock's second consecutive day of gains.Vertex Pharmaceuticals Inc. closed 8.93% below its 52-week high of $533.67, which the company reached on July 7th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc.  rose 4.21% to $254.39, Krystal Biotech Inc.  fell 2.41% to $341.79, and Arcturus Therapeutics Holdings Inc.  fell 3.29% to $6.18.Trading volume  remained 237,521 below its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data comp","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"VERX":"Vertex, Inc.","VRTX":"福泰制药"},"translate_title":"尽管每日上涨，但与竞争对手相比，Vertex Pharmaceuticals Inc. 股票周四表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VERX":1.5,"VRTX":1.5},"content_text":"DJ Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rose 1.88% to $486.03 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.51% to 7,533.77 and Dow Jones Industrial Average  falling 0.20% to 52,552.97. \n\n\n     This was the stock's second consecutive day of gains. \n\n\n     Vertex Pharmaceuticals Inc. closed 8.93% below its 52-week high of $533.67, which the company reached on July 7th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ rose 4.21% to $254.39, Krystal Biotech Inc. (KRYS) fell 2.41% to $341.79, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 3.29% to $6.18. \n\n\n     Trading volume (1.4 M) remained 237,521 below its 50-day average volume of 1.6 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 16, 2026. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 16, 2026 16:36 ET (20:36 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}